WA
WuXi AppTec's Corporate Venture Fund
Shanghai, ChinaFounded 2019
WuXi AppTec's Corporate Venture Fund primarily focuses its investments on the pharmaceutical, biotechnology, oncology, and life science sectors. The fund strategically supports companies and technologies that align with and enhance WuXi AppTec's integrated Contract Research, Development, and Manufacturing Organization (CRDMO) model, particularly those expanding capabilities in new modalities and drug discovery.
100% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months. Their most common stage is series-c (67% of deals). Average disclosed round size is $71.3M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
—
Top Stage
Series C
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
Top Co-Investors
Temasek Holdings1 shared
IDG Capital1 shared
HSG1 shared
Medicxi1 shared
GV (Google Ventures)1 shared
Blue Pool Capital1 shared
Horizon Ventures1 shared
Nan Fung Group1 shared
Deerfield1 shared
Boyu Capital1 shared
Panacea Venture1 shared
WI Harper1 shared
KTB Network1 shared
Trinity Ventures1 shared
Last updated: 10 April 2026